《睡眠專業人士雜誌》
星期四, 七月 23, 2026
LivaNova PLC, a market-leading medical technology company, today announced that it met the primary endpoints for its OSPREY randomized controlled trial (RCT), Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with its safety endpoints, the RCT achieved statistical significance of its primary endpoint responder rates1,2 between the treatment […]
Sleep Specialists, LLC (DBA 2Z Medical) announces that Zzoma is now covered by a growing number of leading health insurance providers. This expanded coverage significantly increases access to this innovative, mask-free treatment option for individuals with positional OSA across the United States. Zzoma is an FDA-cleared positional therapy device indicated […]
雖然持續性正壓呼吸療法（CPAP）仍是阻塞性睡眠呼吸中止症（OSA）的黃金標準治療方式，但已有充分證據顯示，許多患者在長期遵從治療及耐受性方面面臨困難。¹ 文獻指出，CPAP 的未遵從率仍高達 34%，且過去二十年來幾乎未見改善。² 由於 […]
EnsoData and Nonin partner to address the underserved and undiagnosed sleep apnea patient population with a collaborative home sleep apnea testing approach. The partnership will combine the recently FDA-cleared EnsoSleep PPG software as a medical device (SaMD) algorithm with Nonin’s WristOx2® Model 3150 reusable wrist-worn device, offering sleep labs an […]
Incannex Healthcare Inc., a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies, is pleased to announce that patient dosing has commenced in the Company’s Phase 2/3 clinical trial to assess the safety and efficacy of IHL-42X in patients with obstructive sleep apnea (OSA). IHL-42X is the Company’s […]
IntelliPAP™ is a new optional tool for physicians to use in noninvasive ventilation for patients with respiratory insufficiency and obstructive sleep apnea (OSA). This innovative device automatically adjusts the positive end-expiratory pressure (PEEP) levels in response to sleep-disordered breathing (SDB) events. To enhance safety, clinicians can set minimum and maximum […]
ZOLL® has announced today that a new analysis of data from the remedē® System Pivotal Trial suggests favorable outcomes for heart failure (HF) patients with central sleep apnea (CSA). The analysis was performed post-hoc using a hierarchical endpoint comprised of mortality, HF hospitalization, and health status. The new analysis was […]
Sleep Specialists, LLC, developers of the FDA-cleared Zzoma® positional therapy device, and ISD Health Solutions, the leading provider of sleep disorder treatment in the Caribbean, today announced a partnership to bring the benefits of Zzoma to patients suffering from mild to moderate positional obstructive sleep apnea (OSA). This collaboration comes […]
It’s well understood and accepted that sleep position, in particular the supine position in which a person sleeps on their back with their face and abdomen facing upwards, is associated with an increase in sleep-disordered breathing.1 While over half of all cases of obstructive sleep apnea (OSA) are classified as […]
As the prevalence of atrial fibrillation (AF) continues to rise, particularly among the aging population, its connection with obstructive sleep apnea (OSA) has become increasingly evident.1 Patients with AF seeking treatment for OSA often present with a complex medical history that includes a number of comorbidities, such as hypertension, acid […]
